Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
10/1999
10/20/1999EP0950089A1 Methods for the production of bacteria containing eukaryotic genes
10/20/1999EP0949930A1 Thermostable phosphatases
10/20/1999EP0663958A4 Inhibition of cyst formation by cytoskeletal specific drugs.
10/20/1999EP0628057B1 Use of a therapeutical COMPOSITION FOR THE TREATMENT OF THERMAL INJURY
10/20/1999CN1232505A Nucleic acid sequences that encode cell growth regulatory protein and uses thereof
10/20/1999CN1232503A Tumor necrosis factor related ligand
10/20/1999CN1232501A Modified TIE-2 -receptor ligands
10/20/1999CN1232500A Neuritin, a neurogene
10/20/1999CN1232499A Human growth gene and short stature gene region
10/20/1999CN1232498A Guanine exchange factor of RHO GTPase and nucleic acid encoding it
10/20/1999CN1232497A AGE-1 polypeptides and related molecules and methods
10/20/1999CN1232469A RET ligand (RetL) for stimulating neural and renal growth
10/20/1999CN1232468A Acquired resistance NPR genes and uses thereof
10/20/1999CN1232467A Isolated nucleic acid molecule encoding cancer associated antigen, antigen itself, and uses thereof
10/20/1999CN1232365A Biological material embedded in hydrogels, process for embedding thereof, and its use as artificial seed
10/20/1999CN1232087A Polynucleotide molecules encoding neospora proteins
10/20/1999CN1232086A Transcription factor controlling phenylpropanol biosynthesis pathway
10/20/1999CN1231822A Control cell for use in identification of common acute lymphoblast leukemia
10/19/1999US5969215 Dna construct which is free of genes which specify resistance to antibiotics. the regeneration step may include callus formation on a hormone-free medium, particularly suitable for sugar beet.
10/19/1999US5969213 Methods and compositions for the production of stably transformed fertile monocot plants and cells thereof
10/19/1999US5969210 Reporter gene produces a fluorescent protein, sorting insulin-producing pancreatic islet cells from non-insulin-producing pancreatic islet cells by fluorescence activated cell sorting (facs).
10/19/1999US5969125 Polynucleotideds that encode polypeptides that can be used to generate antibodies to prevent, treat, and reduce effects of disease
10/19/1999US5969120 Dna molecule with synthetically mutated retinoblastoma gene encoding a mutated protein; therapy for a tumor cell with mutation in cyclin gene; antitumor agents
10/19/1999US5969110 Antibodies which are immunoreactive with a human tyrosine kinase ligand protein
10/19/1999US5969102 Lymphocyte surface receptor that binds CAML, nucleic acids encoding the same and methods of use thereof
10/19/1999US5969093 Secreted proteins
10/19/1999US5968981 Endothelins and alpha-adrenergic agonist using retinoids for cardiovascular disorders
10/19/1999US5968920 Increase glutathione peroxidase activity for reducing levels of peroxides in cells or tissues
10/19/1999US5968905 Administering cholinergic differentiation factor/leukemia inhibitory factor to adrenal medullary chromaffin cells or to injured nerves
10/19/1999US5968831 Cell control used to confirm enzymatic activity
10/19/1999US5968829 Human CNS neural stem cells
10/19/1999US5968827 Cellular aggregate stabilized culture and process for the development of embryos from a proembryogenic strain for use in vine regeneration techniques
10/19/1999US5968823 Bird cells genetically engineered with exogenous nucleic acid coding mammalian transport protein; screening for compounds to treat brain disorders; alzheimer's/huntington's/ parkinson's diseases
10/19/1999US5968822 Polynucleotide encoding a polypeptide having heparanase activity and expression of same in transduced cells
10/19/1999US5968821 Adenovirus vector containing nucleotide sequence coding polypeptide which binds and inhibits cyclin kinase; screening for agonist or antagonist to cell propagation; develop immunogen; antitumor agents; diagnostic model for disease
10/19/1999US5968819 DNA encoding a hypothalamic atypical neuropeptide Y/peptide YY receptor (Y5)
10/19/1999US5968809 Methods and compositions for synthesis of long chain poly-unsaturated fatty acids
10/19/1999US5968793 Specific gene activation by chimeric Gal4 transcription factors in stable transgenic plants
10/19/1999US5968791 Modifying fatty acyl composition of triglycerides by growing plant to seed; plant has dna for expression of foreign enzyme which inserts carbon chain of length c8 to c14 or c20 or greater fatty acyl-coenzyme a substrate into sn2 postion
10/19/1999US5968789 Method of producing a taxane-type diterpene and a method of obtaining cultured cells which produce the taxane-type diterpene at a high rate
10/19/1999US5968780 Dendritic cell-derived growth factor
10/19/1999US5968777 DNA encoding seryl t-RNA synthetase
10/19/1999US5968776 Multimeric hybrid gene encoding a chimeric protein which confers protection against parainfluenza virus and respiratory syncytial virus
10/19/1999US5968768 CD6 ligand encoding sequence
10/19/1999US5968753 Peptides which displace a monoclonal antibody bound to a cell surface antigen on a target cell; for separating specific cells like cd34 positive hematopoeitic stem cells from a heterogeneous cell population
10/19/1999US5968750 Humanized green fluorescent protein genes and methods
10/19/1999US5968747 Polynucleotide encoding polypeptide; therapy for prevention and treatment of cancer, autoimmune diseases, developmental defects, nervous system disorders
10/19/1999US5968744 Human cornichon molecule
10/19/1999US5968737 Method of identifying inhibitors of glutathione S-transferase (GST) gene expression
10/19/1999US5968546 Keratinocyte culture from precursor cells
10/19/1999US5968511 ErbB3 antibodies
10/19/1999US5968502 Genetic engineering of proteins in cells
10/19/1999US5968501 Genetically engineering, transformation
10/19/1999CA2119974C Human cell adhesion molecule and nucleic acid sequences
10/17/1999CA2268457A1 Mammalian rad1 genes, polypeptides and methods of use
10/16/1999CA2269192A1 Novel g protein coupled receptor
10/14/1999WO1999051781A1 Hepatitis c virus ns5b compositions and methods of use thereof
10/14/1999WO1999051779A2 Glaucoma therapeutics and diagnostics
10/14/1999WO1999051763A1 Corneal organ culture system for chemical toxicity tests of consumer products
10/14/1999WO1999051759A1 Particle mediated transformation of soybean with glyphosate selection
10/14/1999WO1999051744A2 A interleukin-1 receptor antagonist and uses thereof
10/14/1999WO1999051742A2 Dadd, death activator death domain protein
10/14/1999WO1999051741A2 Lyst protein complexes and lyst interacting proteins
10/14/1999WO1999051732A1 Secreted proteins and polynucleotides encoding them
10/14/1999WO1999051727A2 Human nucleic acid sequences of normal ovary tissue
10/14/1999WO1999051720A2 Methods for production of therapeutic cytokines
10/14/1999WO1999051719A1 Methods and apparatus for the conditioning of cartilage replacement tissue
10/14/1999WO1999051642A1 Antibody variants and fragments thereof
10/14/1999WO1999051641A1 G-protein fusion receptors and chimeric gabab receptors
10/14/1999WO1999051640A1 Human oxidized ldl receptor
10/14/1999WO1999051639A1 An integrin heterodimer and a subunit thereof
10/14/1999WO1999051625A2 Peptides causing formation of compact structures
10/14/1999WO1999051622A1 Avian il-15 nucleotides and polypeptides, and methods of immunizing poultry using avian il-15
10/14/1999WO1999051275A2 Mesenchymal stem cells as immunosuppressants
10/14/1999WO1999051265A1 Nucleic acid encoding hyaluronan synthase and methods of use
10/14/1999WO1999051263A2 Methods and modified cells for the treatment of cancer
10/14/1999WO1999051248A1 New combined preparation for the treatment of neoplasic diseases or of infectious diseases
10/14/1999WO1999051247A1 Use of human mesenchymal stem cells to induce t-cell apoptosis
10/14/1999WO1999051206A1 Cationic lipid formulation delivering nucleic acid to peritoneal tumors
10/14/1999WO1999051185A2 Human galactosyl transferases
10/14/1999WO1999043809A3 Protease-activated receptor 4 and uses thereof
10/14/1999WO1999042579A3 Caf1-related protein
10/14/1999WO1999041399A9 Methods for purified aav vector production
10/14/1999WO1999040189A3 Cdnas encoding secreted proteins
10/14/1999WO1999039724A9 Treatment of bony defects with osteoblast precursor cells
10/14/1999WO1999038952A3 Cells or tissues with increased protein factors and methods of making and using same
10/14/1999WO1999037660A9 Meth1 and meth2 polynucleotides and polypeptides
10/14/1999WO1999031225A3 Human phosphatases
10/14/1999WO1999028462A3 Polypeptides and nucleic acids encoding the same
10/14/1999DE19816129A1 T-Zellrezeptor-Expressionskassette T-cell receptor expression cassette
10/14/1999DE19816116A1 Preparation of conditionally immortalized immortalization-helper cells, used to immortalize mammalian cells, e.g. for production of hybridomas
10/14/1999CA2327885A1 Methods and apparatus for the conditioning of cartilage replacement tissue
10/14/1999CA2326130A1 Cationic lipid formulation delivering nucleic acid to peritoneal tumors
10/14/1999CA2326066A1 A interleukin-1 receptor antagonist and uses thereof
10/14/1999CA2325562A1 Lyst protein complexes and lyst interacting proteins
10/14/1999CA2325339A1 Dadd, death activator death domain protein
10/14/1999CA2325334A1 G-protein fusion receptors and chimeric gabab receptors
10/14/1999CA2325331A1 Particle mediated transformation of soybean with glyphosate selection
10/14/1999CA2325016A1 Hepatitis c virus ns5b compositions and methods of use thereof
10/14/1999CA2325007A1 Human galactosyl transferases